Ha Tay Pharmaceutical JSC (HNX: DHT)
Health Care · Pharmaceuticals · VN
₫50,200.00
0.00% today · -29.0% 1Y
Ha Tay Pharmaceutical JSC (HNX: DHT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $193.22M.
Over the last twelve months the share price has lost 29.0%, trading between 46.82K and 78.91K.
Tweenvest scores Ha Tay Pharmaceutical JSC across four factors: quality 66/100, value 22/100, growth 30/100. Its strongest factor is quality.
DHT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $193.22M
- Revenue (TTM)
- $94.09M
- P/E
- 124.54
- EPS
- 403.09
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- ₫78,909.09
- 52-week low
- ₫46,818.18
- Avg volume (3M)
- —
- Shares outstanding
- 99.63M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SCI Pharmtech, Inc.TWSE: 4119 | $203.32M | NT$54.40 | -2.16% |
| Humedix Co., Ltd.KOSDAQ: A200670 | $196.90M | ₩25,650.00 | -0.19% |
| Seikagaku CorporationTSE: 4548 | $195.53M | ¥567.00 | -0.70% |
| Newron Pharmaceuticals S.p.A.SWX: NWRN | $194.03M | CHF7.59 | -6.53% |
| Beacon Pharmaceuticals PLCDSE: BEACONPHAR | $192.63M | Tk102.70 | +0.10% |
| Korea United Pharm Inc.KOSE: A033270 | $189.84M | ₩17,860.00 | +1.88% |
| BioVersys AGSWX: BIOV | $187.08M | CHF26.50 | -1.85% |
| NGL Fine-Chem LimitedBSE: 524774 | $186.76M | Rs2,925.65 | +0.01% |
Figures last refreshed Oct 11, 2026.